News Novo Nordisk’s Ziltivekimab Misses Primary Endpoint in Pivotal Cardiovascular Trial pharminent August 1, 2026
Manufacturing Lilly and Resilience invest $750M in diabetes and obesity drug device supply pharminent July 31, 2026
M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026
News Amgen’s Repatha Wins Positive CHMP Opinion for Preventing First Heart Attacks and Strokes pharminent July 30, 2026
News Vertex, AbCellera Partner on Next-Generation T-Cell Engagers for Autoimmune Disease pharminent July 29, 2026
M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026
News GSK Unveils Three-Year Restructuring to Fund Late-Stage R&D Ahead of Patent Cliff pharminent July 28, 2026
Clinical Data Altimmune rises as GLP-1/GIP drug curbs heavy drinking in mid-stage study pharminent July 28, 2026
News AstraZeneca Says Drug Pricing Is ‘Evolving’ in Response to Trump’s Most-Favored-Nation Policy pharminent July 27, 2026
M&A / Deals Argenx deepens immuno expertise with $2.2B Forte Biosciences buy pharminent July 27, 2026
News EMA CHMP Recommends Twelve New Medicines for Approval at July 2026 Meeting pharminent July 24, 2026
News Lilly’s Retatrutide Hits 22.6% Weight Loss in Phase 3, But Cardiovascular Benefit Remains Elusive pharminent July 23, 2026
Regulatory GSK’s $10.6B Nuvalent bet pays off early as FDA approves lung cancer drug pharminent July 23, 2026
News Arrowhead’s Plozasiran Cuts Triglycerides Roughly 80% in Two Phase 3 Trials pharminent July 22, 2026
Clinical Data Arrowhead hits ‘best-case scenario’ with latest results for fat-lowering drug pharminent July 22, 2026
Manufacturing Speciality versus diversity: the four-way CDMO race in outsourced HPAPI manufacturing pharminent July 22, 2026
Manufacturing Samsung Biologics: geographic diversification is a sound business decision pharminent July 22, 2026
Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026
Manufacturing Cellares and Papillon partner for PPL-001 manufacturing automation pharminent July 22, 2026
News Samsung Biologics Acquires Swiss CDMO PolyPeptide in $1.81bn All-Cash Deal pharminent July 20, 2026
M&A / Deals Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics pharminent July 20, 2026
